KOCH KEVIN (CIK 1185829) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-08-14). Recent activity: Buy EWTX (17,968 shares), Sell EWTX (7,972 shares), Buy EWTX (10,417 shares), Sell EWTX (4,276 shares), Buy EWTX (100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Buy | 17,968 | $0 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 7,972 | $106,745 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Buy | 10,417 | $0 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 4,276 | $70,340 |
| 2025-03-11 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Buy | 100 | $18 |
| 2025-03-11 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 100 | $3,000 |
| 2025-02-07 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Buy | 8,636 | $1,554 |
| 2025-02-07 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 8,636 | $259,339 |
| 2025-02-07 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Buy | 900 | $11,799 |
| 2025-02-07 | Edgewise Therapeutics, Inc. (EWTX) | President and CEO | Sell | 900 | $28,017 |
Source: SEC Form 4 filings · as of 2025-08-14